biotech · Coronary Artery Disease · Bronchopulmonary Dysplasia · ASBP
Aspire Biopharma Holdings
Aspire Biopharma is a biotech organization headquartered in Humacao, USA. It trades on NYSE under ticker ASBP. Primary therapeutic focus areas include Coronary Artery Disease, Bronchopulmonary Dysplasia, Heart Failure, C
Humacao, USA HQ
2019 Founded
Public company Type
ASBP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Humacao, USA
- Founded
- 2019
- Programs
- 8
- Drugs
- 8
- Patents
- 1
ACT-20-MSC
Phase 2 · mab · COVID-19 Pneumonia
ACT-20-MSC for COVID-19 Pneumonia is a Phase 2 program (mab) at Aspire Biopharma Holdings with 1 ClinicalTrials.gov record(s).
Internal code AHS 20-03
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Aspire Biopharma Holdings
- Phase
- Phase 2
- Modality
- mab
- Indication
- COVID-19 Pneumonia
- Status
- active
- Trials
- 1